Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?

[1]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[2]  R. Ghossein,et al.  Patients with Multifocal Macroscopic Papillary Thyroid Carcinoma Have a Low Risk of Recurrence at Early Follow-Up after Total Thyroidectomy and Radioactive Iodine Treatment , 2016, European Thyroid Journal.

[3]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[4]  Al AfifAyham,et al.  Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis , 2015 .

[5]  J. Shah,et al.  Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure. , 2015, Thyroid : official journal of the American Thyroid Association.

[6]  J. Jonklaas,et al.  Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012. , 2015, The Journal of clinical endocrinology and metabolism.

[7]  H. Park,et al.  Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma , 2015, Head & neck.

[8]  S. Roman,et al.  Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. , 2015, The Journal of clinical endocrinology and metabolism.

[9]  E. Kandil,et al.  Total Thyroidectomy is Associated with Increased Risk of Complications for Low- and High-Volume Surgeons , 2014, Annals of surgical oncology.

[10]  Jae Bok Lee,et al.  Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. , 2014, Journal of cancer research and therapeutics.

[11]  M. Barczyński,et al.  Multifocal papillary thyroid carcinoma—a consensus report of the European Society of Endocrine Surgeons (ESES) , 2014, Langenbeck's Archives of Surgery.

[12]  C. Hsueh,et al.  Prognosis of Multifocal Papillary Thyroid Carcinoma , 2013, International journal of endocrinology.

[13]  E. Kandil,et al.  Hemithyroidectomy: A Meta-Analysis of Postoperative Need for Hormone Replacement and Complications , 2012, ORL.

[14]  Tao Huang,et al.  Multifocality and Total Tumor Diameter Predict Central Neck Lymph Node Metastases in Papillary Thyroid Microcarcinoma , 2013, Annals of Surgical Oncology.

[15]  J. Shah,et al.  Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. , 2012, Surgery.

[16]  Yong-xue Zhu,et al.  Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  J. Shah,et al.  The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. , 2011, Surgery.

[18]  R. Tuttle,et al.  Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer , 2011, Clinical endocrinology.

[19]  Abie H. Mendelsohn,et al.  Surgery for papillary thyroid carcinoma: is lobectomy enough? , 2010, Archives of otolaryngology--head & neck surgery.

[20]  T. Sebo,et al.  Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. , 2008, Surgery.

[21]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[22]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[24]  B. Hankey,et al.  Surveillance, Epidemiology, and End Results Program , 1999 .

[25]  E. Bergstralh,et al.  Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? , 1998, Surgery.

[26]  E. Strong,et al.  Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. , 1993, American journal of surgery.